loader
Please Wait
Applying Filters...

CSBio CSBio

X

Applications:

DL-Glutamic acid is used in topical dosage forms such as lotions, soaps, creams, patches, etc.

Ingredient(s): DL-Glutamic Acid

Dosage Form:

Category: Topical

Route of Administration (Grade): Topical
Pharmacopoeia Reference: NA

Technical Specifications: Molecular weight: 147.1 g/mol

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

DL-Glutamic acid is used in topical dosage forms such as lotions, soaps, creams, patches, etc.

Ingredient(s): DL-Glutamic Acid

Dosage Form:

Category: Topical

Route of Administration (Grade): Topical
Pharmacopoeia Reference: NA

Technical Specifications: Molecular weight: 147.1 g/mol

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

EUDRAGIT® L 100-55 polymer is used in delayed and sustained release coatings to enhance solubility for poorly soluble drugs in solid oral dosage forms such as tablets, capsules, etc.

Ingredient(s): Methacrylic Acid - Ethyl Acrylate Copolymer

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Oral
Pharmacopoeia Reference: NA

Technical Specifications: Available as powder; Other grades- EUDRAGIT® L 30 D-55

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

EUDRAGIT® L 100-55 polymer is used in delayed and sustained release coatings to enhance solubility for poorly soluble drugs in solid oral dosage forms such as tablets, capsules, etc.

Ingredient(s): Methacrylic Acid - Ethyl Acrylate Copolymer

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Oral
Pharmacopoeia Reference: NA

Technical Specifications: Available as powder; Other grades- EUDRAGIT® L 30 D-55

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

DL-Valine is used in semi-solid topical dosage forms such as gel, cream, lotion, etc.

Ingredient(s): L-Valine Excipient

Dosage Form:

Category: Topical

Route of Administration (Grade): Topical
Pharmacopoeia Reference: NA

Technical Specifications: Molecular weight: 117.1 g/mol

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

EUDRAGIT® RL, an insoluble, highly permeable polymer used in combination with EUDRAGIT® RS in customized release formulations in oral solid dosage forms such as tablets, capsuels, etc.

Ingredient(s): Ammonia Methacrylate Copolymer Type A

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Oral
Pharmacopoeia Reference: NA

Technical Specifications: Other grades- EUDRAGIT® RL 12,5, EUDRAGIT® RL 30 D, EUDRAGIT® RL PO

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

DL-Valine is used in semi-solid topical dosage forms such as gel, cream, lotion, etc.

Ingredient(s): L-Valine Excipient

Dosage Form:

Category: Topical

Route of Administration (Grade): Topical
Pharmacopoeia Reference: NA

Technical Specifications: Molecular weight: 117.1 g/mol

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

EUDRAGIT® RL, an insoluble, highly permeable polymer used in combination with EUDRAGIT® RS in customized release formulations in oral solid dosage forms such as tablets, capsuels, etc.

Ingredient(s): Ammonia Methacrylate Copolymer Type A

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Oral
Pharmacopoeia Reference: NA

Technical Specifications: Other grades- EUDRAGIT® RL 12,5, EUDRAGIT® RL 30 D, EUDRAGIT® RL PO

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

L-Tryptophan is used in topical formulations such as lotions and creams.

Ingredient(s): L Tryptophan Excipient

Dosage Form:

Category: Topical

Route of Administration (Grade): Topical
Pharmacopoeia Reference: NA

Technical Specifications: Molecular weight: 204.23 g/mol

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

EUDRAGIT® RS, a functional sustained / extended release polymer, used in combination with EUDRAGIT® RL for customized release profiles, to provide tailor coating permeability for tablets, capsules, pellets, etc.

Ingredient(s): Ammonio Methacrylate Copolymer Type B

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Oral
Pharmacopoeia Reference: NA

Technical Specifications: Available as granules; Other grades- EUDRAGIT® RS 12,5, EUDRAGIT® RS 30 D, EUDRAGIT® RS PO

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

L-Lysine HCl is used in semi-solid dosage forms such as creams, lotions, shampoos, etc.

Ingredient(s): L Lysine HCl Excipient

Dosage Form:

Category: Topical

Route of Administration (Grade): Topical
Pharmacopoeia Reference: NA

Technical Specifications: Molecular weight: 182.7 g/mol

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

EUDRAGIT® RS, a functional sustained / extended release polymer, used in combination with EUDRAGIT® RL for customized release profiles, to provide tailor coating permeability for tablets, capsules, pellets, etc.

Ingredient(s): Ammonio Methacrylate Copolymer Type B

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Oral
Pharmacopoeia Reference: NA

Technical Specifications: Available as granules; Other grades- EUDRAGIT® RS 12,5, EUDRAGIT® RS 30 D, EUDRAGIT® RS PO

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

L-Lysine HCl is used in semi-solid dosage forms such as creams, lotions, shampoos, etc.

Ingredient(s): L Lysine HCl Excipient

Dosage Form:

Category: Topical

Route of Administration (Grade): Topical
Pharmacopoeia Reference: NA

Technical Specifications: Molecular weight: 182.7 g/mol

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

L-Leucine is used as a lubricating agent and taste masking agent in oral solid dosage forms such as tablets, & capsules. It is also used in various topical formulations such as creams and lotions.

Ingredient(s): L-Leucine

Dosage Form:

Category: Taste Masking

Route of Administration (Grade): Oral, Topical
Pharmacopoeia Reference: NA

Technical Specifications: Molecular weight: 131.2 g/mol

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

L-Leucine is used as a lubricating agent and taste masking agent in oral solid dosage forms such as tablets, & capsules. It is also used in various topical formulations such as creams and lotions.

Ingredient(s): L-Leucine

Dosage Form:

Category: Taste Masking

Route of Administration (Grade): Oral, Topical
Pharmacopoeia Reference: NA

Technical Specifications: Molecular weight: 131.2 g/mol

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

L-Leucine is used as a lubricating agent and taste masking agent in oral solid dosage forms such as tablets, & capsules. It is also used in various topical formulations such as creams and lotions.

Ingredient(s): L-Leucine

Dosage Form:

Category: Lubricants & Glidants

Route of Administration (Grade): Oral, Topical
Pharmacopoeia Reference: NA

Technical Specifications: Molecular weight: 131.2 g/mol

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

L-Leucine is used as a lubricating agent and taste masking agent in oral solid dosage forms such as tablets, & capsules. It is also used in various topical formulations such as creams and lotions.

Ingredient(s): L-Leucine

Dosage Form:

Category: Lubricants & Glidants

Route of Administration (Grade): Oral, Topical
Pharmacopoeia Reference: NA

Technical Specifications: Molecular weight: 131.2 g/mol

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

L-Aspartic Acid is widely used in topical dosage forms such as creams, ointments & lotions.

Ingredient(s): L-Aspartic Acid

Dosage Form:

Category: Topical

Route of Administration (Grade): Topical
Pharmacopoeia Reference: NA

Technical Specifications: Molecular weight: 133.1 g/mol

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

L-Aspartic Acid is widely used in topical dosage forms such as creams, ointments & lotions.

Ingredient(s): L-Aspartic Acid

Dosage Form:

Category: Topical

Route of Administration (Grade): Topical
Pharmacopoeia Reference: NA

Technical Specifications: Molecular weight: 133.1 g/mol

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

L-Alanine is used in topical semi-solid dosage forms such as creams, lotions, ointments, gels, etc.

Ingredient(s): L-Alanine

Dosage Form:

Category: Topical

Route of Administration (Grade): Topical
Pharmacopoeia Reference: NA

Technical Specifications: Molecular Weight: 89.1 g/mol

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

L-Alanine is used in topical semi-solid dosage forms such as creams, lotions, ointments, gels, etc.

Ingredient(s): L-Alanine

Dosage Form:

Category: Topical

Route of Administration (Grade): Topical
Pharmacopoeia Reference: NA

Technical Specifications: Molecular Weight: 89.1 g/mol

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

L-Threonine is used in semi-sold topical formulations such as lotion, cream, gel, ointment, etc.

Ingredient(s): L Threonine Excipient

Dosage Form:

Category: Topical

Route of Administration (Grade): Topical
Pharmacopoeia Reference: NA

Technical Specifications: Molecular weight: 119.1 g/mol

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

L-Threonine is used in semi-sold topical formulations such as lotion, cream, gel, ointment, etc.

Ingredient(s): L Threonine Excipient

Dosage Form:

Category: Topical

Route of Administration (Grade): Topical
Pharmacopoeia Reference: NA

Technical Specifications: Molecular weight: 119.1 g/mol

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

L-Serine is used in topical semi-solid formulations like cream, lotions and gel.

Ingredient(s): L Serine Excipient

Dosage Form:

Category: Topical

Route of Administration (Grade): Topical
Pharmacopoeia Reference: NA

Technical Specifications: Molecular weight: 105.1 g/mol

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

L-Serine is used in topical semi-solid formulations like cream, lotions and gel.

Ingredient(s): L Serine Excipient

Dosage Form:

Category: Topical

Route of Administration (Grade): Topical
Pharmacopoeia Reference: NA

Technical Specifications: Molecular weight: 105.1 g/mol

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

EUDRAGIT® E polymer provides a range of attractive coating solutions to improve swallowability, mask unpleasant tastes or odors, in various dosage forms such as tablets, ODTs, capsules, powders etc.

Ingredient(s): Amino Methacrylate Copolymer

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Oral
Pharmacopoeia Reference: NA

Technical Specifications: Available as granules; Other grades- EUDRAGIT® E 12,5, EUDRAGIT® E PO.

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

EUDRAGIT® E polymer provides a range of attractive coating solutions to improve swallowability, mask unpleasant tastes or odors, in various dosage forms such as tablets, ODTs, capsules, powders etc.

Ingredient(s): Amino Methacrylate Copolymer

Dosage Form:

Category: Taste Masking

Route of Administration (Grade): Oral
Pharmacopoeia Reference: NA

Technical Specifications: Available as granules; Other grades- EUDRAGIT® E 12,5, EUDRAGIT® E PO.

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

EUDRAGIT® E polymer provides a range of attractive coating solutions to improve swallowability, mask unpleasant tastes or odors, in various dosage forms such as tablets, ODTs, capsules, powders etc.

Ingredient(s): Amino Methacrylate Copolymer

Dosage Form:

Category: Taste Masking

Route of Administration (Grade): Oral
Pharmacopoeia Reference: NA

Technical Specifications: Available as granules; Other grades- EUDRAGIT® E 12,5, EUDRAGIT® E PO.

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

EUDRAGIT® E polymer provides a range of attractive coating solutions to improve swallowability, mask unpleasant tastes or odors, in various dosage forms such as tablets, ODTs, capsules, powders etc.

Ingredient(s): Amino Methacrylate Copolymer

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Oral
Pharmacopoeia Reference: NA

Technical Specifications: Available as granules; Other grades- EUDRAGIT® E 12,5, EUDRAGIT® E PO.

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

EUDRAGIT® E polymer provides a range of attractive coating solutions to improve swallowability, mask unpleasant tastes or odors, in various dosage forms such as tablets, ODTs, capsules, powders etc.

Ingredient(s): Amino Methacrylate Copolymer

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Oral
Pharmacopoeia Reference: NA

Technical Specifications: Available as granules; Other grades- EUDRAGIT® E 12,5, EUDRAGIT® E PO.

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

EUDRAGIT® E polymer provides a range of attractive coating solutions to improve swallowability, mask unpleasant tastes or odors, in various dosage forms such as tablets, ODTs, capsules, powders etc.

Ingredient(s): Amino Methacrylate Copolymer

Dosage Form:

Category: Disintegrants & Superdisintegrants

Route of Administration (Grade): Oral
Pharmacopoeia Reference: NA

Technical Specifications: Available as granules; Other grades- EUDRAGIT® E 12,5, EUDRAGIT® E PO.

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

EUDRAGIT® E polymer provides a range of attractive coating solutions to improve swallowability, mask unpleasant tastes or odors, in various dosage forms such as tablets, ODTs, capsules, powders etc.

Ingredient(s): Amino Methacrylate Copolymer

Dosage Form:

Category: Disintegrants & Superdisintegrants

Route of Administration (Grade): Oral
Pharmacopoeia Reference: NA

Technical Specifications: Available as granules; Other grades- EUDRAGIT® E 12,5, EUDRAGIT® E PO.

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

EUDRAGIT® E polymer provides a range of attractive coating solutions to improve swallowability, mask unpleasant tastes or odors, in various dosage forms such as tablets, ODTs, capsules, powders etc.

Ingredient(s): Amino Methacrylate Copolymer

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Oral
Pharmacopoeia Reference: NA

Technical Specifications: Available as granules; Other grades- EUDRAGIT® E 12,5, EUDRAGIT® E PO.

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

EUDRAGIT® E polymer provides a range of attractive coating solutions to improve swallowability, mask unpleasant tastes or odors, in various dosage forms such as tablets, ODTs, capsules, powders etc.

Ingredient(s): Amino Methacrylate Copolymer

Dosage Form:

Category: Film Formers & Plasticizers

Route of Administration (Grade): Oral
Pharmacopoeia Reference: NA

Technical Specifications: Available as granules; Other grades- EUDRAGIT® E 12,5, EUDRAGIT® E PO.

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

EUDRAGIT® E polymer provides a range of attractive coating solutions to improve swallowability, mask unpleasant tastes or odors, in various dosage forms such as tablets, ODTs, capsules, powders etc.

Ingredient(s): Amino Methacrylate Copolymer

Dosage Form:

Category: Film Formers & Plasticizers

Route of Administration (Grade): Oral
Pharmacopoeia Reference: NA

Technical Specifications: Available as granules; Other grades- EUDRAGIT® E 12,5, EUDRAGIT® E PO.

TMF Summit 2024

Not Confirmed

envelop Contact Supplier

Applications:

Direct compression; Powder blend, filler-binder, taste masking agent for slow to medium fast disintegrating tablets, lozenge tablets, swallowable tablets, effervescent tablets, dry suspensions (for sachet and capsule fillings)

Ingredient(s): Isomalt

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 25; Particle size distribution (?m): d10 95, d50 220, d90 360; Bulk density (g/l): 410; Total water K. F. (%): 5,0; Loss on drying (%) (105 pa, 7 h at 25 ?C): 0,21

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

Ingredient(s): Lauryl Sulfate, Povidone, Polyvinyl Acetate, Hydrated Silica

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Pharmacel® 102 has good flow properties enabling high speed direct compression tableting. It is a ideal choice for direct compression & dry granulation formulations and it also has some lubrication properties for smooth tableting experience.

Ingredient(s): Microcrystalline Cellulose

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to USP-NF, Ph.Eur., JP, IP

Technical Specifications: Density- Tapped density- 440 g/l, Bulk density- 310 g/l; Particle size- D10- 40 ?m, D50- 90 ?m, D90-180 ?m; Hausner ratio-1,42

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Direct compression; Powder blend, filler-binder, taste masking agent for slow to medium fast disintegrating tablets, lozenge tablets, swallowable tablets, effervescent tablets, dry suspensions (for sachet and capsule fillings)

Ingredient(s): Isomalt

Dosage Form:

Category: Taste Masking

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 25; Particle size distribution (?m): d10 95, d50 220, d90 360; Bulk density (g/l): 410; Total water K. F. (%): 5,0; Loss on drying (%) (105 pa, 7 h at 25 ?C): 0,21

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Primellose® croscarmellose sodium is an effective super-disintegrant ,suitable for a variety of tablet and capsule formulations. It is effective when used intragranular and/or extragranular in granular formulations.

Ingredient(s): Croscarmellose Sodium

Dosage Form:

Category: Disintegrants & Superdisintegrants

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to USP-NF, Ph.Eur., JP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

Ingredient(s): Povidone, Lauryl Sulfate, Polyvinyl Acetate, Hydrated Silica

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Direct compression; Powder blend, filler-binder, taste masking agent for slow to medium fast disintegrating tablets, lozenge tablets, swallowable tablets, effervescent tablets, dry suspensions (for sachet and capsule fillings)

Ingredient(s): Isomalt

Dosage Form:

Category: Taste Masking

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 25; Particle size distribution (?m): d10 95, d50 220, d90 360; Bulk density (g/l): 410; Total water K. F. (%): 5,0; Loss on drying (%) (105 pa, 7 h at 25 ?C): 0,21

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

Ingredient(s): Povidone, Lauryl Sulfate, Polyvinyl Acetate, Hydrated Silica

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Primellose® croscarmellose sodium is an effective super-disintegrant ,suitable for a variety of tablet and capsule formulations. It is effective when used intragranular and/or extragranular in granular formulations.

Ingredient(s): Croscarmellose Sodium

Dosage Form:

Category: Disintegrants & Superdisintegrants

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to USP-NF, Ph.Eur., JP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Direct compression; Powder blend, filler-binder, taste masking agent for slow to medium fast disintegrating tablets, lozenge tablets, swallowable tablets, effervescent tablets, dry suspensions (for sachet and capsule fillings)

Ingredient(s): Isomalt

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 25; Particle size distribution (?m): d10 95, d50 220, d90 360; Bulk density (g/l): 410; Total water K. F. (%): 5,0; Loss on drying (%) (105 pa, 7 h at 25 ?C): 0,21

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Primojel® is a superdisintegrant suitable for a variety of tablet & capsule formulations. In higher concentrations, It can act as a dissolution enhancing agent.

Ingredient(s): Sodium Starch Glycolate

Dosage Form:

Category: Disintegrants & Superdisintegrants

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to USP-NF, Ph.Eur., JP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic solubilizer, emulsifier and co-emulsifier

Ingredient(s): Polysorbate 20

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Direct compression; Powder blend, filler-binder, taste masking agent for slow to medium fast disintegrating tablets, lozenge tablets, swallowable tablets, effervescent tablets, dry suspensions (for sachet and capsule fillings)

Ingredient(s): Isomalt

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 25; Particle size distribution (?m): d10 95, d50 220, d90 360; Bulk density (g/l): 410; Total water K. F. (%): 5,0; Loss on drying (%) (105 pa, 7 h at 25 ?C): 0,21

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Primojel® is a superdisintegrant suitable for a variety of tablet & capsule formulations. In higher concentrations, It can act as a dissolution enhancing agent.

Ingredient(s): Sodium Starch Glycolate

Dosage Form:

Category: Disintegrants & Superdisintegrants

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to USP-NF, Ph.Eur., JP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic solubilizer, emulsifier and co-emulsifier

Ingredient(s): Polysorbate 20

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic solubilizer, emulsifier and co-emulsifier

Ingredient(s): Polysorbate 20

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Direct compression; Powder blend, filler-binder, taste masking agent for slow to medium fast disintegrating tablets, lozenge tablets, swallowable tablets, effervescent tablets, dry suspensions (for sachet and capsule fillings)

Ingredient(s): Isomalt

Dosage Form:

Category: Taste Masking

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 25; Particle size distribution (?m): d10 95, d50 220, d90 360; Bulk density (g/l): 410; Total water K. F. (%): 5,0; Loss on drying (%) (105 pa, 7 h at 25 ?C): 0,21

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Primojel® is a superdisintegrant suitable for a variety of tablet & capsule formulations. In higher concentrations, It can act as a dissolution enhancing agent.

Ingredient(s): Sodium Starch Glycolate

Dosage Form:

Category: Disintegrants & Superdisintegrants

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to USP-NF, Ph.Eur., JP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

SuperTab® 11SD offers the best compactability of all grades of lactose, and it is well suited to direct compression applications. Due to the low moisture content, it is used in the formulations containing moisture sensitive drugs.

Ingredient(s): Anhydrous Lactose

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to Ph. Eur., Lactose monograph / USP-NF, JP Anhydrous lactose monograph

Technical Specifications: Density- Tapped density- 906 g/l, Bulk density- 722 g/l; Particle size- D10-15 ?m, D50- 170 ?m, D90- 340 ?m; Hausner ratio-1,25

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic solubilizer, emulsifier and co-emulsifier

Ingredient(s): Polysorbate 20

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Wet granulation, Fluid bed agglomeration, Roller compaction

Ingredient(s): Isomalt

Dosage Form:

Category: Taste Masking

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 42; Particle size distribution (?m): d10 5, d50 15, d90 45; Bulk density (g/l): 500; Total water K. F. (%): 2,7; Loss on drying (%) (105 pa, 7 h at 25 ?C): 0,26

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic solubilizer, emulsifier and co-emulsifier

Ingredient(s): Polysorbate 60

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Pharmacel® 101 is a pharmaceutical excipient that acts as a pharmaceutical binder & filler for wet and dry granulation as it ensures uniform granulation and drying processes. It also provides excellent compaction and disintegration.

Ingredient(s): Microcrystalline Cellulose

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to USP-NF, Ph.Eur., JP, IP

Technical Specifications: Density- Tapped density- 440 g/l, Bulk density- 280 g/l; Particle size- D10- 25 ?m, D50- 60 ?m, D90- 20 ?m; Hausner ratio-1,57

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Wet granulation, Fluid bed agglomeration, Roller compaction

Ingredient(s): Isomalt

Dosage Form:

Category: Taste Masking

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 42; Particle size distribution (?m): d10 5, d50 15, d90 45; Bulk density (g/l): 500; Total water K. F. (%): 2,7; Loss on drying (%) (105 pa, 7 h at 25 ?C): 0,26

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

PHARMATOSE 200M

URL Supplier Web Content
LM Application #LearnMore

Applications:

Pharmatose® 200M is a pharmaceutical excipient that is a highly consistent monohydrate lactose which delivers good compaction properties. This lactose type is typically used in oral dosage forms like tablets and pharmaceutical capsules.

Ingredient(s): Lactose Monohydrate

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to USP-NF, Ph.Eur., JP lactose monohydrate monograph

Technical Specifications: Density- Tapped density- 857 g/l, Bulk density- 589 g/l; Particle size- D10- 5 ?m, D50- 40 ?m, D90- 120 ?m; Hausner ratio- 1,46

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic solubilizer, emulsifier and co-emulsifier

Ingredient(s): Polysorbate 60

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

High-shear granulation, fluid bed agglomeration, Wet granulation, Roller compaction

Ingredient(s): Isomalt

Dosage Form:

Category: Taste Masking

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 42; Particle size distribution (?m): d10 5, d50 15, d90 45; Bulk density (g/l): 500; Total water K. F. (%): 2,6; Loss on drying (%) (105 pa, 7 h at 25 ?C): 0,21

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic solubilizer, emulsifier and co-emulsifier

Ingredient(s): Polysorbate 60

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

High-shear granulation, fluid bed agglomeration, Wet granulation, Roller compaction

Ingredient(s): Isomalt

Dosage Form:

Category: Taste Masking

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 42; Particle size distribution (?m): d10 5, d50 15, d90 45; Bulk density (g/l): 500; Total water K. F. (%): 2,6; Loss on drying (%) (105 pa, 7 h at 25 ?C): 0,21

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

PHARMATOSE 200M

URL Supplier Web Content
LM Application #LearnMore

Applications:

Pharmatose® 200M is a pharmaceutical excipient that is a highly consistent monohydrate lactose which delivers good compaction properties. This lactose type is typically used in oral dosage forms like tablets and pharmaceutical capsules.

Ingredient(s): Lactose Monohydrate

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to USP-NF, Ph.Eur., JP lactose monohydrate monograph

Technical Specifications: Density- Tapped density- 857 g/l, Bulk density- 589 g/l; Particle size- D10- 5 ?m, D50- 40 ?m, D90- 120 ?m; Hausner ratio- 1,46

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

PHARMATOSE 200M

URL Supplier Web Content
LM Application #LearnMore

Applications:

Pharmatose® 200M is a pharmaceutical excipient that is a highly consistent monohydrate lactose which delivers good compaction properties. This lactose type is typically used in oral dosage forms like tablets and pharmaceutical capsules.

Ingredient(s): Lactose Monohydrate

Dosage Form:

Category: Granulation

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to USP-NF, Ph.Eur., JP lactose monohydrate monograph

Technical Specifications: Density- Tapped density- 857 g/l, Bulk density- 589 g/l; Particle size- D10- 5 ?m, D50- 40 ?m, D90- 120 ?m; Hausner ratio- 1,46

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Fluid bed agglomeration, Wet granulation, Roller compaction

Ingredient(s): Isomalt

Dosage Form:

Category: Taste Masking

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 25; Particle size distribution (?m): d50 22, d90 41

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic solubilizer, emulsifier and co-emulsifier

Ingredient(s): Polysorbate 60

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic solubilizer, emulsifier and co-emulsifier

Ingredient(s): Polysorbate 80

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Fluid bed agglomeration, Wet granulation, Roller compaction

Ingredient(s): Isomalt

Dosage Form:

Category: Taste Masking

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 25; Particle size distribution (?m): d50 22, d90 41

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

SuperTab® 11SD is a pharmaceutical excipient which is a highly consistent, spray-dried lactose enabling efficient tableting by offering free flow properties. It also offers excellent compaction properties and content uniformity.

Ingredient(s): Lactose Monohydrate

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to USP-NF, Ph.Eur., JP lactose monohydrate monograph

Technical Specifications: Density- Tapped density- 716 g/l, Bulk density- 599 g/l; Particle size- D10-50 ?m, D50- 120 ?m, D90- 220 ?m; Hausner ratio-1,2

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

High-boiled lozenges

Ingredient(s): Isomalt

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 25; Particle size distribution (?m): d10 660, d50 1510, d90 2560; Bulk density (g/l): 850

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic solubilizer, emulsifier and co-emulsifier

Ingredient(s): Polysorbate 80

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

High-boiled lozenges

Ingredient(s): Isomalt

Dosage Form:

Category: Taste Masking

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 25; Particle size distribution (?m): d10 660, d50 1510, d90 2560; Bulk density (g/l): 850

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic solubilizer, emulsifier and co-emulsifier

Ingredient(s): Polysorbate 80

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic solubilizer, emulsifier and co-emulsifier

Ingredient(s): Polysorbate 80

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Capsule filling, Dry blend, Hot melt extrusion, Dry suspension (bottle, sachet, capsule fillings), Starter pellets

Ingredient(s): Isomalt

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 25; Particle size distribution (?m): d10 270, d50 400, d90 530; Bulk density (g/l): 820; Total water K. F. (%): 2,3; Loss on drying (%) (105 pa, 7 h at 25 ?C): 0,12

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Capsule filling, Dry blend, Hot melt extrusion, Dry suspension (bottle, sachet, capsule fillings), Starter pellets

Ingredient(s): Isomalt

Dosage Form:

Category: Taste Masking

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 25; Particle size distribution (?m): d10 270, d50 400, d90 530; Bulk density (g/l): 820; Total water K. F. (%): 2,3; Loss on drying (%) (105 pa, 7 h at 25 ?C): 0,12

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubiliser, Plasticizer for coating & polymeric matrices, Nonionic emulsifier for O-W emulsions.

Ingredient(s): Polyoxyl 40 Hydrogenated Castor Oil

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur: Macrogolglycerol Hydroxystearate, USP-NF: Polyoxyl 40 hydrogenated castor oil

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Capsule filling, Dry blend, Hot melt extrusion, Dry suspension (bottle, sachet, capsule fillings), Starter pellets

Ingredient(s): Isomalt

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 25; Particle size distribution (?m): d10 270, d50 400, d90 530; Bulk density (g/l): 820; Total water K. F. (%): 2,3; Loss on drying (%) (105 pa, 7 h at 25 ?C): 0,12

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubiliser, Plasticizer for coating & polymeric matrices, Nonionic emulsifier for O-W emulsions.

Ingredient(s): Polyoxyl 40 Hydrogenated Castor Oil

Dosage Form:

Category: Film Formers & Plasticizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur: Macrogolglycerol Hydroxystearate, USP-NF: Polyoxyl 40 hydrogenated castor oil

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Capsule filling, Dry blend, Hot melt extrusion, Dry suspension (bottle, sachet, capsule fillings), Starter pellets

Ingredient(s): Isomalt

Dosage Form:

Category: Taste Masking

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 25; Particle size distribution (?m): d10 270, d50 400, d90 530; Bulk density (g/l): 820; Total water K. F. (%): 2,3; Loss on drying (%) (105 pa, 7 h at 25 ?C): 0,12

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubiliser, Plasticizer for coating & polymeric matrices, Nonionic emulsifier for O-W emulsions.

Ingredient(s): Polyoxyl 40 Hydrogenated Castor Oil

Dosage Form:

Category: Film Formers & Plasticizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur: Macrogolglycerol Hydroxystearate, USP-NF: Polyoxyl 40 hydrogenated castor oil

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubiliser, Plasticizer for coating & polymeric matrices, Nonionic emulsifier for O-W emulsions.

Ingredient(s): Polyoxyl 40 Hydrogenated Castor Oil

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur: Macrogolglycerol Hydroxystearate, USP-NF: Polyoxyl 40 hydrogenated castor oil

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Capsule filling, Dry blend, Hot melt extrusion, Dry suspension (bottle, sachet, capsule fillings), Starter pellets

Ingredient(s): Isomalt

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 25; Particle size distribution (?m): d10 270, d50 400, d90 530; Bulk density (g/l): 820; Total water K. F. (%): 2,3; Loss on drying (%) (105 pa, 7 h at 25 ?C): 0,12

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Capsule filling, Dry blend, Hot melt extrusion, Dry suspension (bottle, sachet, capsule fillings), Starter pellets

Ingredient(s): Isomalt

Dosage Form:

Category: Taste Masking

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 25; Particle size distribution (?m): d10 270, d50 400, d90 530; Bulk density (g/l): 820; Total water K. F. (%): 2,3; Loss on drying (%) (105 pa, 7 h at 25 ?C): 0,12

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubiliser, Plasticizer for coating & polymeric matrices, Nonionic emulsifier for O-W emulsions.

Ingredient(s): Polyoxyl 40 Hydrogenated Castor Oil

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur: Macrogolglycerol Hydroxystearate, USP-NF: Polyoxyl 40 hydrogenated castor oil

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Wetting agent, reduces disintegration time, Ionic solubilizer, high HLB anionic emulsifier for semi-solids and foams.

Ingredient(s): Sodium Lauryl Sulfate

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Sodium Laurilsulfate; USP-NF, JP: Sodium Lauryl Sulfate

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Pan coating (Sugar free), Syrup, Palatability improvement in liquid formulations

Ingredient(s): Isomalt

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 42; Particle size distribution (?m): d10 260, d50 520, d90 800; Bulk density (g/l): 780; Total water K. F. (%): 2,8; Loss on drying (%) (105 pa, 7 h at 25 ?C): 0,02

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Wetting agent, reducing disintegration time, direct compression, Hydrophilic lubricant, effervescent tablets.

Ingredient(s): Sodium Lauryl Sulfate

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Sodium Laurilsulfate; USP-NF, JP: Sodium Lauryl Sulfate

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Pan coating (Sugar free), Syrup, Palatability improvement in liquid formulations

Ingredient(s): Isomalt

Dosage Form:

Category: Taste Masking

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 42; Particle size distribution (?m): d10 260, d50 520, d90 800; Bulk density (g/l): 780; Total water K. F. (%): 2,8; Loss on drying (%) (105 pa, 7 h at 25 ?C): 0,02

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Wetting agent, reducing disintegration time, direct compression, Hydrophilic lubricant, effervescent tablets.

Ingredient(s): Sodium Lauryl Sulfate

Dosage Form:

Category: Lubricants & Glidants

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Sodium Laurilsulfate; USP-NF, JP: Sodium Lauryl Sulfate

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Pan coating (Sugar free), Syrup, Palatability improvement in liquid formulations

Ingredient(s): Isomalt

Dosage Form:

Category: Taste Masking

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 42; Particle size distribution (?m): d10 260, d50 520, d90 800; Bulk density (g/l): 780; Total water K. F. (%): 2,8; Loss on drying (%) (105 pa, 7 h at 25 ?C): 0,02

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Wetting agent, reducing disintegration time, direct compression, Hydrophilic lubricant, effervescent tablets.

Ingredient(s): Sodium Lauryl Sulfate

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Sodium Laurilsulfate; USP-NF, JP: Sodium Lauryl Sulfate

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Pan coating (Sugar free), Syrup, Palatability improvement in liquid formulations

Ingredient(s): Isomalt

Dosage Form:

Category: Taste Masking

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 42; Particle size distribution (?m): d10 260, d50 520, d90 800; Bulk density (g/l): 780; Total water K. F. (%): 2,8; Loss on drying (%) (105 pa, 7 h at 25 ?C): 0,02

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Galeniq 721 is used for direct compression, powder blend, pharmaceutical filler and binder, taste-masking agent for chewable tablets and orally disintegrating tablets (ODTs) and dry suspensions (for sachet and capsule fillers).

Ingredient(s): Isomalt

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 42; Particle size distribution (?m): d10 90, d50 210, d90 360; Bulk density (g/l): 400; Total water K. F. (%): 2,9; Loss on drying (%) (105 pa, 7 h at 25 ?C): 0,12

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Wetting agent, reducing disintegration time, direct compression, Hydrophilic lubricant, effervescent tablets.

Ingredient(s): Sodium Lauryl Sulfate

Dosage Form:

Category: Lubricants & Glidants

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Sodium Laurilsulfate; USP-NF, JP: Sodium Lauryl Sulfate

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Galeniq 721 is used for direct compression, powder blend, pharmaceutical filler and binder, taste-masking agent for chewable tablets and orally disintegrating tablets (ODTs) and dry suspensions (for sachet and capsule fillers).

Ingredient(s): Isomalt

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 42; Particle size distribution (?m): d10 90, d50 210, d90 360; Bulk density (g/l): 400; Total water K. F. (%): 2,9; Loss on drying (%) (105 pa, 7 h at 25 ?C): 0,12

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solvent for lipophilic drugs

Ingredient(s): Isopropyl Myristate, Cetearyl Ethylhexanoate

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Galeniq 721 is used for direct compression, powder blend, pharmaceutical filler and binder, taste-masking agent for chewable tablets and orally disintegrating tablets (ODTs) and dry suspensions (for sachet and capsule fillers).

Ingredient(s): Isomalt

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 42; Particle size distribution (?m): d10 90, d50 210, d90 360; Bulk density (g/l): 400; Total water K. F. (%): 2,9; Loss on drying (%) (105 pa, 7 h at 25 ?C): 0,12

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solvent for lipophilic drugs

Ingredient(s): Isopropyl Myristate, Cetearyl Ethylhexanoate

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Galeniq 721 is used for direct compression, powder blend, pharmaceutical filler and binder, taste-masking agent for chewable tablets and orally disintegrating tablets (ODTs) and dry suspensions (for sachet and capsule fillers).

Ingredient(s): Isomalt

Dosage Form:

Category: Chewable & Orodispersible Aids

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph. Eur., BP, USP-NF, JP

Technical Specifications: Solubility in water at 20°C (g/100g): 42; Particle size distribution (?m): d10 90, d50 210, d90 360; Bulk density (g/l): 400; Total water K. F. (%): 2,9; Loss on drying (%) (105 pa, 7 h at 25 ?C): 0,12

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Plasticizer particularly suitable for tablet coatings. Versatile water or oil miscible solvent in topical formulations.

Ingredient(s): Triacetin

Dosage Form:

Category: Film Formers & Plasticizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP/NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Plasticizer particularly suitable for tablet coatings. Versatile water or oil miscible solvent in topical formulations.

Ingredient(s): Triacetin

Dosage Form:

Category: Film Formers & Plasticizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP/NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Oil fill & solubilizer for lipophilic drugs, Water barrier-repairing, emollient film-former on skin

Ingredient(s): Medium Chain Triglycerides

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP/NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Oil fill & solubilizer for lipophilic drugs, Water barrier-repairing, emollient film-former on skin

Ingredient(s): Medium Chain Triglycerides

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP/NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Oil fill & solubilizer for lipophilic drugs, Water barrier-repairing, emollient film-former on skin

Ingredient(s): Medium Chain Triglycerides

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP/NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Liquid plasticizer with high ADI, hydrophilic solvent & humectant in emulsions, skin penetration enhancer in topical formulaitons.

Ingredient(s): Propylene Glycol

Dosage Form:

Category: Film Formers & Plasticizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., JP, FCC, USP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Liquid plasticizer with high ADI, hydrophilic solvent & humectant in emulsions, skin penetration enhancer in topical formulaitons.

Ingredient(s): Propylene Glycol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., JP, FCC, USP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Liquid plasticizer with high ADI, hydrophilic solvent & humectant in emulsions, skin penetration enhancer in topical formulaitons.

Ingredient(s): Propylene Glycol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., JP, FCC, USP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Liquid plasticizer with high ADI, hydrophilic solvent & humectant in emulsions, skin penetration enhancer in topical formulaitons.

Ingredient(s): Propylene Glycol

Dosage Form:

Category: Film Formers & Plasticizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., JP, FCC, USP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Liquid plasticizer with high ADI, hydrophilic solvent & humectant in emulsions, skin penetration enhancer in topical formulaitons.

Ingredient(s): Propylene Glycol

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., JP, FCC, USP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Liquid plasticizer with high ADI, hydrophilic solvent & humectant in emulsions, skin penetration enhancer in topical formulaitons.

Ingredient(s): Propylene Glycol

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., JP, FCC, USP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Liquid plasticizer with high ADI, hydrophilic solvent & humectant in emulsions, skin penetration enhancer in topical formulaitons.

Ingredient(s): Propylene Glycol

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., JP, FCC, USP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Liquid plasticizer with high ADI, hydrophilic solvent & humectant in emulsions, skin penetration enhancer in topical formulaitons.

Ingredient(s): Propylene Glycol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., JP, FCC, USP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solvent for injectables and oral formulations for animal health

Ingredient(s): Pyrrolidone

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solvent for injectables and oral formulations for animal health

Ingredient(s): Pyrrolidone

Dosage Form:

Category: Parenteral

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solvent for injectables and oral formulations for animal health

Ingredient(s): Pyrrolidone

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solvent for injectables and oral formulations for animal health

Ingredient(s): Pyrrolidone

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solvent for injectables and oral formulations for animal health

Ingredient(s): Pyrrolidone

Dosage Form:

Category: Parenteral

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor for semi-solids. Viscosity regulator.

Ingredient(s): Cetyl Alcohol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Cetyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor for semi-solids. Viscosity regulator.

Ingredient(s): Cetyl Alcohol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Cetyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor for semi-solids. Viscosity regulator.

Ingredient(s): Cetyl Alcohol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Cetyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor for semi-solids. Viscosity regulator.

Ingredient(s): Cetyl Alcohol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Cetyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor for semi-solids. Viscosity regulator.

Ingredient(s): Cetyl Alcohol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Cetyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor for semi-solids. Viscosity regulator.

Ingredient(s): Cetyl Alcohol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Cetyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor for semi-solids. Viscosity regulator.

Ingredient(s): Cetyl Alcohol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Cetyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor for semi-solids, Co-emulsifier and viscosity enhancer

Ingredient(s): Cetostearyl Alcohol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JPE: Cetostearyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor for semi-solids, Co-emulsifier and viscosity enhancer

Ingredient(s): Cetostearyl Alcohol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JPE: Cetostearyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor for semi-solids, Co-emulsifier and viscosity enhancer

Ingredient(s): Cetostearyl Alcohol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JPE: Cetostearyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor for semi-solids, Co-emulsifier and viscosity enhancer

Ingredient(s): Cetostearyl Alcohol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JPE: Cetostearyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor for semi-solids, Co-emulsifier and viscosity enhancer

Ingredient(s): Cetostearyl Alcohol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JPE: Cetostearyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor for semi-solids, Co-emulsifier and viscosity enhancer

Ingredient(s): Cetostearyl Alcohol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JPE: Cetostearyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor for semi-solids, Co-emulsifier and viscosity enhancer

Ingredient(s): Cetostearyl Alcohol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JPE: Cetostearyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor for semi-solids, Co-emulsifier and viscosity enhancer

Ingredient(s): Cetostearyl Alcohol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JPE: Cetostearyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor for semi-solids, Viscosity regulator

Ingredient(s): Cetostearyl Alcohol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JPE: Cetostearyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor for semi-solids, Viscosity regulator

Ingredient(s): Cetostearyl Alcohol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JPE: Cetostearyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor for semi-solids, Viscosity regulator

Ingredient(s): Cetostearyl Alcohol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JPE: Cetostearyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor for semi-solids, Viscosity regulator

Ingredient(s): Cetostearyl Alcohol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JPE: Cetostearyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor for semi-solids, Viscosity regulator

Ingredient(s): Cetostearyl Alcohol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JPE: Cetostearyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor for semi-solids, Viscosity regulator

Ingredient(s): Cetostearyl Alcohol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JPE: Cetostearyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor for semi-solids, Viscosity regulator

Ingredient(s): Cetostearyl Alcohol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JPE: Cetostearyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor for semi-solids, Viscosity regulator

Ingredient(s): Cetostearyl Alcohol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JPE: Cetostearyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Co-emulsifier, viscosity enhancer & anti-tacking agent

Ingredient(s): Glyceryl Monostearate

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Glyceryl monostearate 40-55 (type II), USP-NF: Mono- and di-glycerides

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Co-emulsifier, viscosity enhancer & anti-tacking agent

Ingredient(s): Glyceryl Monostearate

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Glyceryl monostearate 40-55 (type II), USP-NF: Mono- and di-glycerides

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Co-emulsifier, viscosity enhancer & anti-tacking agent

Ingredient(s): Glyceryl Monostearate

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Glyceryl monostearate 40-55 (type II), USP-NF: Mono- and di-glycerides

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Co-emulsifier, viscosity enhancer & anti-tacking agent

Ingredient(s): Glyceryl Monostearate

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Glyceryl monostearate 40-55 (type II), USP-NF: Mono- and di-glycerides

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Co-emulsifier, viscosity enhancer & anti-tacking agent

Ingredient(s): Glyceryl Monostearate

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Glyceryl monostearate 40-55 (type II), USP-NF: Mono- and di-glycerides

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Co-emulsifier, viscosity enhancer & anti-tacking agent

Ingredient(s): Glyceryl Monostearate

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Glyceryl monostearate 40-55 (type II), USP-NF: Mono- and di-glycerides

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Co-emulsifier, viscosity enhancer & anti-tacking agent

Ingredient(s): Glyceryl Monostearate

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Glyceryl monostearate 40-55 (type II), USP-NF: Mono- and di-glycerides

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Co-emulsifier, viscosity enhancer & anti-tacking agent

Ingredient(s): Glyceryl Monostearate

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Glyceryl monostearate 40-55 (type II), USP-NF: Mono- and di-glycerides

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Co-emulsifier, viscosity enhancer & anti-tacking agent

Ingredient(s): Glyceryl Monostearate

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Glyceryl monostearate 40-55 (type II), USP-NF: Mono- and di-glycerides

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Lipophilic lubricant, for sensitive acidic APIs, sustained release melt coating. Used as consistency factor to enhance the viscosity of topical formulations.

Ingredient(s): Hydrogenated Castor Oil

Dosage Form:

Category: Lubricants & Glidants

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., Castor Oil, hydrogenated, USP-NF: Hydrogenated Castor Oil, JP: Hydrogenated Oil

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Lipophilic lubricant, for sensitive acidic APIs, sustained release melt coating. Used as consistency factor to enhance the viscosity of topical formulations.

Ingredient(s): Hydrogenated Castor Oil

Dosage Form:

Category: Lubricants & Glidants

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., Castor Oil, hydrogenated, USP-NF: Hydrogenated Castor Oil, JP: Hydrogenated Oil

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Lipophilic lubricant, for sensitive acidic APIs, sustained release melt coating. Used as consistency factor to enhance the viscosity of topical formulations.

Ingredient(s): Hydrogenated Castor Oil

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., Castor Oil, hydrogenated, USP-NF: Hydrogenated Castor Oil, JP: Hydrogenated Oil

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Lipophilic lubricant, for sensitive acidic APIs, sustained release melt coating. Used as consistency factor to enhance the viscosity of topical formulations.

Ingredient(s): Hydrogenated Castor Oil

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., Castor Oil, hydrogenated, USP-NF: Hydrogenated Castor Oil, JP: Hydrogenated Oil

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Consistency factor with low melting point. Soft sensory effect

Ingredient(s): Myristyl Alcohol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF: Myristyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Consistency factor with low melting point. Soft sensory effect

Ingredient(s): Myristyl Alcohol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF: Myristyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Consistency factor with low melting point. Soft sensory effect

Ingredient(s): Myristyl Alcohol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF: Myristyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Consistency factor with low melting point. Soft sensory effect

Ingredient(s): Myristyl Alcohol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF: Myristyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Consistency factor with low melting point. Soft sensory effect

Ingredient(s): Myristyl Alcohol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF: Myristyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Consistency factor with low melting point. Soft sensory effect

Ingredient(s): Myristyl Alcohol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF: Myristyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor with dry feel, forms crystalline barrier on skin

Ingredient(s): Stearic Acid

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP: Stearic acid 50

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor with dry feel, forms crystalline barrier on skin

Ingredient(s): Stearic Acid

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP: Stearic acid 50

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor with dry feel, forms crystalline barrier on skin

Ingredient(s): Stearic Acid

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP: Stearic acid 50

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor with dry feel, forms crystalline barrier on skin

Ingredient(s): Stearic Acid

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP: Stearic acid 50

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor with dry feel, forms crystalline barrier on skin

Ingredient(s): Stearic Acid

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP: Stearic acid 50

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor with dry feel, forms crystalline barrier on skin

Ingredient(s): Stearic Acid

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP: Stearic acid 50

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Structure-building consistency factor with dry feel, forms crystalline barrier on skin

Ingredient(s): Stearic Acid

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP: Stearic acid 50

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Lipophilic lubricant, for sensitive acidic APIs, Structure-building consistency factor for semi-solids, Viscosity regulator.

Ingredient(s): Stearyl Alcohol

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP: Stearyl Alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Lipophilic lubricant, for sensitive acidic APIs, Structure-building consistency factor for semi-solids, Viscosity regulator.

Ingredient(s): Stearyl Alcohol

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP: Stearyl Alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Lipophilic lubricant, for sensitive acidic APIs, Structure-building consistency factor for semi-solids, Viscosity regulator.

Ingredient(s): Stearyl Alcohol

Dosage Form:

Category: Lubricants & Glidants

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP: Stearyl Alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Lipophilic lubricant, for sensitive acidic APIs, Structure-building consistency factor for semi-solids, Viscosity regulator.

Ingredient(s): Stearyl Alcohol

Dosage Form:

Category: Lubricants & Glidants

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP: Stearyl Alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

Ingredient(s): Polyvinyl Acetate, Sodium Lauryl Sulfate

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Poly(vinyl acetate) dispersion 30 per cent; USP: Polyvinyl Acetate Dispersion

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

Ingredient(s): Polyvinyl Acetate, Sodium Lauryl Sulfate

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Poly(vinyl acetate) dispersion 30 per cent; USP: Polyvinyl Acetate Dispersion

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

Ingredient(s): Polyvinyl Acetate, Sodium Lauryl Sulfate

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Poly(vinyl acetate) dispersion 30 per cent; USP: Polyvinyl Acetate Dispersion

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

Ingredient(s): Polyvinyl Acetate, Sodium Lauryl Sulfate

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Poly(vinyl acetate) dispersion 30 per cent; USP: Polyvinyl Acetate Dispersion

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Ready-to-use direct compression solution for tablets.

Ingredient(s): Crospovidone, Lactose, Povidone

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph.Eur., USP/NF and JP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Ready-to-use direct compression solution for tablets.

Ingredient(s): Crospovidone, Povidone, Lactose

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph.Eur., USP/NF and JP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Ready-to-use direct compression solution for tablets.

Ingredient(s): Crospovidone, Lactose, Povidone

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph.Eur., USP/NF and JP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Ready-to-use direct compression solution for tablets.

Ingredient(s): Crospovidone, Lactose, Povidone

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph.Eur., USP/NF and JP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Ready-to-use direct compression solution for lozenges, chewables and effervescent tablets.

Ingredient(s): Povidone, Lactose

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP/NF and J.P

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Ready-to-use direct compression solution for lozenges, chewables and effervescent tablets.

Ingredient(s): Lactose, Povidone

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP/NF and J.P

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Ready-to-use direct compression solution for lozenges, chewables and effervescent tablets.

Ingredient(s): Povidone, Lactose

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP/NF and J.P

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Ready-to-use direct compression solution for lozenges, chewables and effervescent tablets.

Ingredient(s): Lactose, Povidone

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP/NF and J.P

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Hard fat for suppository matrix, viscosity enhancer

Ingredient(s): Hard Fat

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Hard fat for suppository matrix, viscosity enhancer

Ingredient(s): Hard Fat

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Hard fat for suppository matrix, viscosity enhancer

Ingredient(s): Hard Fat

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Hard fat for suppository matrix, viscosity enhancer

Ingredient(s): Hard Fat

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Hard fat for suppository matrix, viscosity enhancer

Ingredient(s): Hard Fat

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Hard fat for suppository matrix, viscosity enhancer

Ingredient(s): Hard Fat

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Hard fat for suppository matrix, viscosity enhancer

Ingredient(s): Hard Fat

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Hard fat for suppository matrix, viscosity enhancer

Ingredient(s): Hard Fat

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric coating with release above pH 5.5 (non-neutralized powder), fast redispersing for aqueaous and organic coating

Ingredient(s): Ethyl Acrylate and Methyl Methacrylate

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric coating with release above pH 5.5 (non-neutralized powder), fast redispersing for aqueaous and organic coating

Ingredient(s): Ethyl Acrylate and Methyl Methacrylate

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric coating with release above pH 5.5 (non-neutralized powder), fast redispersing for aqueaous and organic coating

Ingredient(s): Ethyl Acrylate and Methyl Methacrylate

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric coating with release above pH 5.5 (non-neutralized powder), fast redispersing for aqueaous and organic coating

Ingredient(s): Ethyl Acrylate and Methyl Methacrylate

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric coating with release above pH 5.5 (non-neutralized powder), fast redispersing for aqueaous and organic coating

Ingredient(s): Ethyl Acrylate and Methyl Methacrylate

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric coating with release above pH 5.5 (non-neutralized powder), fast redispersing for aqueaous and organic coating

Ingredient(s): Ethyl Acrylate and Methyl Methacrylate

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric coating with release above pH 5.5 (non-neutralized powder), fast redispersing for aqueaous and organic coating

Ingredient(s): Ethyl Acrylate and Methyl Methacrylate

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric coating with release above pH 5.5 (non-neutralized powder), fast redispersing for aqueaous and organic coating

Ingredient(s): Ethyl Acrylate and Methyl Methacrylate

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric coating with release above pH 5.5 (partially preneutralized powder)

Ingredient(s): Ethyl Acrylate and Methyl Methacrylate

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Methacrylic Acid

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric coating with release above pH 5.5 (partially preneutralized powder)

Ingredient(s): Ethyl Acrylate and Methyl Methacrylate

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Methacrylic Acid

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric coating with release above pH 5.5 (partially preneutralized powder)

Ingredient(s): Ethyl Acrylate and Methyl Methacrylate

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Methacrylic Acid

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric coating with release above pH 5.5 (partially preneutralized powder)

Ingredient(s): Ethyl Acrylate and Methyl Methacrylate

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Methacrylic Acid

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric coating with release above pH 5.5 (partially preneutralized powder)

Ingredient(s): Ethyl Acrylate and Methyl Methacrylate

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Methacrylic Acid

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric coating with release above pH 5.5 (partially preneutralized powder)

Ingredient(s): Ethyl Acrylate and Methyl Methacrylate

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Methacrylic Acid

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric coating with release above pH 5.5 (partially preneutralized powder)

Ingredient(s): Ethyl Acrylate and Methyl Methacrylate

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Methacrylic Acid

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric coating with release above pH 5.5 (partially preneutralized powder)

Ingredient(s): Ethyl Acrylate and Methyl Methacrylate

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Methacrylic Acid

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric coating with release above pH 5.5 (30 % solids content dispersion)

Ingredient(s): Ethyl Acrylate and Methyl Methacrylate

Dosage Form:

Category: Taste Masking

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Methacrylic Acid

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric coating with release above pH 5.5 (30 % solids content dispersion)

Ingredient(s): Ethyl Acrylate and Methyl Methacrylate

Dosage Form:

Category: Taste Masking

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Methacrylic Acid

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric coating with release above pH 5.5 (30 % solids content dispersion)

Ingredient(s): Ethyl Acrylate and Methyl Methacrylate

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Methacrylic Acid

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric coating with release above pH 5.5 (30 % solids content dispersion)

Ingredient(s): Ethyl Acrylate and Methyl Methacrylate

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Methacrylic Acid

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric coating with release above pH 5.5 (30 % solids content dispersion)

Ingredient(s): Ethyl Acrylate and Methyl Methacrylate

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Methacrylic Acid

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric coating with release above pH 5.5 (30 % solids content dispersion)

Ingredient(s): Ethyl Acrylate and Methyl Methacrylate

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Methacrylic Acid

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric coating with release above pH 5.5 (30 % solids content dispersion)

Ingredient(s): Ethyl Acrylate and Methyl Methacrylate

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Methacrylic Acid

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric coating with release above pH 5.5 (30 % solids content dispersion)

Ingredient(s): Ethyl Acrylate and Methyl Methacrylate

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Methacrylic Acid

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric coating with release above pH 5.5 (30 % solids content dispersion)

Ingredient(s): Ethyl Acrylate and Methyl Methacrylate

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Methacrylic Acid

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Enteric coating with release above pH 5.5 (30 % solids content dispersion)

Ingredient(s): Ethyl Acrylate and Methyl Methacrylate

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Methacrylic Acid

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Taste masking at very low coating levels, suitable for pellets & particles for ODTs.

Ingredient(s): Diethylaminoethyl Methacrylate, Methyl Methacrylate, CETEARETH-12, Sodium Lauryl Sulfate

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Taste masking at very low coating levels, suitable for pellets & particles for ODTs.

Ingredient(s): CETEARETH-12, Methyl Methacrylate, Diethylaminoethyl Methacrylate, Sodium Lauryl Sulfate

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Taste masking at very low coating levels, suitable for pellets & particles for ODTs.

Ingredient(s): CETEARETH-12, Diethylaminoethyl Methacrylate, Sodium Lauryl Sulfate, Methyl Methacrylate

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Taste masking at very low coating levels, suitable for pellets & particles for ODTs.

Ingredient(s): Diethylaminoethyl Methacrylate, Sodium Lauryl Sulfate, Methyl Methacrylate, CETEARETH-12

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Taste masking at very low coating levels, suitable for pellets & particles for ODTs.

Ingredient(s): Methyl Methacrylate, Diethylaminoethyl Methacrylate, CETEARETH-12, Sodium Lauryl Sulfate

Dosage Form:

Category: Taste Masking

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Taste masking at very low coating levels, suitable for pellets & particles for ODTs.

Ingredient(s): Sodium Lauryl Sulfate, Diethylaminoethyl Methacrylate, Methyl Methacrylate, CETEARETH-12

Dosage Form:

Category: Taste Masking

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

Ingredient(s): Sodium Lauryl Sulfate, Polyvinyl Acetate

Dosage Form:

Category: Taste Masking

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Poly(vinyl acetate) dispersion 30 per cent; USP: Polyvinyl Acetate Dispersion

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

Ingredient(s): Polyvinyl Acetate, Sodium Lauryl Sulfate

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Poly(vinyl acetate) dispersion 30 per cent; USP: Polyvinyl Acetate Dispersion

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

Ingredient(s): Polyvinyl Acetate, Sodium Lauryl Sulfate

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Poly(vinyl acetate) dispersion 30 per cent; USP: Polyvinyl Acetate Dispersion

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

Ingredient(s): Sodium Lauryl Sulfate, Polyvinyl Acetate

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Poly(vinyl acetate) dispersion 30 per cent; USP: Polyvinyl Acetate Dispersion

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

Ingredient(s): Polyvinyl Acetate, Sodium Lauryl Sulfate

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Poly(vinyl acetate) dispersion 30 per cent; USP: Polyvinyl Acetate Dispersion

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

Ingredient(s): Polyvinyl Acetate, Sodium Lauryl Sulfate

Dosage Form:

Category: Taste Masking

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Poly(vinyl acetate) dispersion 30 per cent; USP: Polyvinyl Acetate Dispersion

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilization, dispersion, crystallization inhibition, instant release matrices & spray drying

Ingredient(s): Povidone

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilization, dispersion, crystallization inhibition, instant release matrices & spray drying

Ingredient(s): Povidone

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilization, dispersion, crystallization inhibition, instant release matrices & spray drying

Ingredient(s): Povidone

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

KOLLIDON 30 LP

URL Supplier Web Content
LM Application #LearnMore

Applications:

Binder for peroxide sensitive drugs in solid oral dosage forms. Drug solubilizer with low peroxide in transdermal patches.

Ingredient(s): Povidone

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Povidone

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

KOLLIDON 30 LP

URL Supplier Web Content
LM Application #LearnMore

Applications:

Binder for peroxide sensitive drugs in solid oral dosage forms. Drug solubilizer with low peroxide in transdermal patches.

Ingredient(s): Povidone

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Povidone

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

KOLLIDON 30 LP

URL Supplier Web Content
LM Application #LearnMore

Applications:

Binder for peroxide sensitive drugs in solid oral dosage forms. Drug solubilizer with low peroxide in transdermal patches.

Ingredient(s): Povidone

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Povidone

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

KOLLIDON 30 LP

URL Supplier Web Content
LM Application #LearnMore

Applications:

Binder for peroxide sensitive drugs in solid oral dosage forms. Drug solubilizer with low peroxide in transdermal patches.

Ingredient(s): Povidone

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Povidone

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

KOLLIDON 30 LP

URL Supplier Web Content
LM Application #LearnMore

Applications:

Binder for peroxide sensitive drugs in solid oral dosage forms. Drug solubilizer with low peroxide in transdermal patches.

Ingredient(s): Povidone

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Povidone

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Maximum disintegration

Ingredient(s): Crospovidone

Dosage Form:

Category: Disintegrants & Superdisintegrants

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type A

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Maximum disintegration

Ingredient(s): Crospovidone

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type A

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Maximum disintegration

Ingredient(s): Crospovidone

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type A

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Maximum disintegration

Ingredient(s): Crospovidone

Dosage Form:

Category: Disintegrants & Superdisintegrants

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type A

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Maximum disintegration

Ingredient(s): Crospovidone

Dosage Form:

Category: Disintegrants & Superdisintegrants

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type A

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Roller compaction & direct compression including slight disintegration functionality, Reduces sedimentation in suspensions. Solubilizer in transdermal patches.

Ingredient(s): Crospovidone

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type B

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Roller compaction & direct compression including slight disintegration functionality, Reduces sedimentation in suspensions. Solubilizer in transdermal patches.

Ingredient(s): Crospovidone

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type B

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Roller compaction & direct compression including slight disintegration functionality, Reduces sedimentation in suspensions. Solubilizer in transdermal patches.

Ingredient(s): Crospovidone

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type B

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Roller compaction & direct compression including slight disintegration functionality, Reduces sedimentation in suspensions. Solubilizer in transdermal patches.

Ingredient(s): Crospovidone

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type B

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Roller compaction & direct compression including slight disintegration functionality, Reduces sedimentation in suspensions. Solubilizer in transdermal patches.

Ingredient(s): Crospovidone

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type B

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Roller compaction & direct compression including slight disintegration functionality, Reduces sedimentation in suspensions. Solubilizer in transdermal patches.

Ingredient(s): Crospovidone

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type B

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Roller compaction & direct compression including slight disintegration functionality, Reduces sedimentation in suspensions. Solubilizer in transdermal patches.

Ingredient(s): Crospovidone

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type B

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

Ingredient(s): Lauryl Sulfate, Povidone, Polyvinyl Acetate, Hydrated Silica

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

Ingredient(s): Lauryl Sulfate, Povidone, Polyvinyl Acetate, Hydrated Silica

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

Ingredient(s): Lauryl Sulfate, Povidone, Polyvinyl Acetate, Hydrated Silica

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Binder with fine particle size for roller compaction & direct compression

Ingredient(s): Copovidone K25-31

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Binder with fine particle size for roller compaction & direct compression

Ingredient(s): Copovidone K25-31

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dry binder in tablets, capsules and granules, as a film-forming agent in tablet coatings and subcoatings, and as a film-forming agent in topical sprays. Widely used in HME processes.

Ingredient(s): Copovidone K25-31

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dry binder in tablets, capsules and granules, as a film-forming agent in tablet coatings and subcoatings, and as a film-forming agent in topical sprays. Widely used in HME processes.

Ingredient(s): Copovidone K25-31

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dry binder in tablets, capsules and granules, as a film-forming agent in tablet coatings and subcoatings, and as a film-forming agent in topical sprays. Widely used in HME processes.

Ingredient(s): Copovidone K25-31

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dry binder in tablets, capsules and granules, as a film-forming agent in tablet coatings and subcoatings, and as a film-forming agent in topical sprays. Widely used in HME processes.

Ingredient(s): Copovidone K25-31

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Binder with fine particle size for roller compaction & direct compression

Ingredient(s): Copovidone K25-31

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Binder with fine particle size for roller compaction & direct compression

Ingredient(s): Copovidone K25-31

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dry binder in tablets, capsules and granules, as a film-forming agent in tablet coatings and subcoatings, and as a film-forming agent in topical sprays. Widely used in HME processes.

Ingredient(s): Copovidone K25-31

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dry binder in tablets, capsules and granules, as a film-forming agent in tablet coatings and subcoatings, and as a film-forming agent in topical sprays. Widely used in HME processes.

Ingredient(s): Copovidone K25-31

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Binder with fine particle size for roller compaction & direct compression

Ingredient(s): Copovidone K25-31

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Binder with fine particle size for roller compaction & direct compression

Ingredient(s): Copovidone K25-31

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dry binder in tablets, capsules and granules, as a film-forming agent in tablet coatings and subcoatings, and as a film-forming agent in topical sprays. Widely used in HME processes.

Ingredient(s): Copovidone K25-31

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Binder with fine particle size for roller compaction & direct compression

Ingredient(s): Copovidone K25-31

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dry binder in tablets, capsules and granules, as a film-forming agent in tablet coatings and subcoatings, and as a film-forming agent in topical sprays. Widely used in HME processes.

Ingredient(s): Copovidone K25-31

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

KOLLIDON VA64 FINE

URL Supplier Web Content
LM Application #LearnMore

Applications:

Binder with fine particle size for roller compaction & direct compression

Ingredient(s): Copovidone K25-31

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

KOLLIDON VA64 FINE

URL Supplier Web Content
LM Application #LearnMore

Applications:

Binder with fine particle size for roller compaction & direct compression

Ingredient(s): Copovidone K25-31

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

KOLLIDON VA64 FINE

URL Supplier Web Content
LM Application #LearnMore

Applications:

Binder with fine particle size for roller compaction & direct compression

Ingredient(s): Copovidone K25-31

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

KOLLIDON VA64 FINE

URL Supplier Web Content
LM Application #LearnMore

Applications:

Binder with fine particle size for roller compaction & direct compression

Ingredient(s): Copovidone K25-31

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

KOLLIDON VA64 FINE

URL Supplier Web Content
LM Application #LearnMore

Applications:

Binder with fine particle size for roller compaction & direct compression

Ingredient(s): Copovidone K25-31

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

KOLLIDON VA64 FINE

URL Supplier Web Content
LM Application #LearnMore

Applications:

Binder with fine particle size for roller compaction & direct compression

Ingredient(s): Copovidone K25-31

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

KOLLIDON VA64 FINE

URL Supplier Web Content
LM Application #LearnMore

Applications:

Binder with fine particle size for roller compaction & direct compression

Ingredient(s): Copovidone K25-31

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic emulsifier for O-W emulsions

Ingredient(s): CETEARETH-12

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Macrogol cetostearyl ether 12

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic emulsifier for O-W emulsions

Ingredient(s): CETEARETH-12

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Macrogol cetostearyl ether 12

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic emulsifier for O-W emulsions

Ingredient(s): CETEARETH-12

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Macrogol cetostearyl ether 12

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic emulsifier for O-W emulsions

Ingredient(s): CETEARETH-12, Polyoxyl 20 Cetostearyl Ether

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Macrogol cetostearyl ether 20, USP-NF: Polyoxyl 20 cetostearyl ether

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic emulsifier for O-W emulsions

Ingredient(s): CETEARETH-12, Polyoxyl 20 Cetostearyl Ether

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Macrogol cetostearyl ether 20, USP-NF: Polyoxyl 20 cetostearyl ether

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic emulsifier for O-W emulsions

Ingredient(s): CETEARETH-12, Polyoxyl 20 Cetostearyl Ether

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Macrogol cetostearyl ether 20, USP-NF: Polyoxyl 20 cetostearyl ether

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Anionic emulsifier and consistency factor combination for creams and lotions, Self emulsifying wax

Ingredient(s): Cetostearyl Alcohol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Cetostearyl alcohol (type A), emulsifying

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Anionic emulsifier and consistency factor combination for creams and lotions, Self emulsifying wax

Ingredient(s): Cetostearyl Alcohol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Cetostearyl alcohol (type A), emulsifying

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Anionic emulsifier and consistency factor combination for creams and lotions, Self emulsifying wax

Ingredient(s): Cetostearyl Alcohol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Cetostearyl alcohol (type A), emulsifying

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Self-emulsifying and consistency building, easy-to-use base for dermatological creams

Ingredient(s): Sodium Cetostearyl Sulfate, Sodium Lauryl Sulfate, Cetostearyl Alcohol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Self-emulsifying and consistency building, easy-to-use base for dermatological creams

Ingredient(s): Sodium Cetostearyl Sulfate, Sodium Lauryl Sulfate, Cetostearyl Alcohol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Self-emulsifying and consistency building, easy-to-use base for dermatological creams

Ingredient(s): Sodium Cetostearyl Sulfate, Sodium Lauryl Sulfate, Cetostearyl Alcohol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Anionic emulsifier

Ingredient(s): Sodium Cetostearyl Sulfate

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Sodium cetostearyl sulfate

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Anionic emulsifier

Ingredient(s): Sodium Cetostearyl Sulfate

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Sodium cetostearyl sulfate

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Anionic emulsifier

Ingredient(s): Sodium Cetostearyl Sulfate

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Sodium cetostearyl sulfate

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic emulsifier for O-W emulsions, Solubilizer

Ingredient(s): Polyoxyl 15 Hydroxystearate

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Macrogol 15 Hydroxystearate; USP-NF: Polyoxyl 15 Hydroxystearate

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic emulsifier for O-W emulsions, Solubilizer

Ingredient(s): Polyoxyl 15 Hydroxystearate

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Macrogol 15 Hydroxystearate; USP-NF: Polyoxyl 15 Hydroxystearate

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic emulsifier for O-W emulsions, Solubilizer

Ingredient(s): Polyoxyl 15 Hydroxystearate

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Macrogol 15 Hydroxystearate; USP-NF: Polyoxyl 15 Hydroxystearate

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic emulsifier for O-W emulsions, Solubilizer

Ingredient(s): Polyoxyl 15 Hydroxystearate

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Macrogol 15 Hydroxystearate; USP-NF: Polyoxyl 15 Hydroxystearate

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic emulsifier for O-W emulsions, Solubilizer

Ingredient(s): Polyoxyl 15 Hydroxystearate

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Macrogol 15 Hydroxystearate; USP-NF: Polyoxyl 15 Hydroxystearate

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

Ingredient(s): Sodium Lauryl Sulfate, Polyvinyl Acetate

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Poly(vinyl acetate) dispersion 30 per cent; USP: Polyvinyl Acetate Dispersion

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic emulsifier for O-W emulsions, Solubilizer

Ingredient(s): Polyoxyl 35 Castor Oil

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur. Macrogolglycerol Ricinoleate 35; USP-NF, JPE: Polyoxyl 35 Castor Oil

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic emulsifier for O-W emulsions, Solubilizer

Ingredient(s): Polyoxyl 35 Castor Oil

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur. Macrogolglycerol Ricinoleate 35; USP-NF, JPE: Polyoxyl 35 Castor Oil

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic emulsifier for O-W emulsions, Solubilizer

Ingredient(s): Polyoxyl 35 Castor Oil

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur. Macrogolglycerol Ricinoleate 35; USP-NF, JPE: Polyoxyl 35 Castor Oil

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic emulsifier for O-W emulsions, Solubilizer

Ingredient(s): Polyoxyl 35 Castor Oil

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur. Macrogolglycerol Ricinoleate 35; USP-NF, JPE: Polyoxyl 35 Castor Oil

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic emulsifier for O-W emulsions, Solubilizer

Ingredient(s): Polyoxyl 35 Castor Oil

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur. Macrogolglycerol Ricinoleate 35; USP-NF, JPE: Polyoxyl 35 Castor Oil

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic emulsifier for O-W emulsions, Solubilizer

Ingredient(s): Polyoxyl 35 Castor Oil

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur. Macrogolglycerol Ricinoleate 35; USP-NF, JPE: Polyoxyl 35 Castor Oil

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic emulsifier for O-W emulsions, Solubilizer

Ingredient(s): Polyoxyl 35 Castor Oil

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur. Macrogolglycerol Ricinoleate 35; USP-NF, JPE: Polyoxyl 35 Castor Oil

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic emulsifier for O-W emulsions, Solubilizer

Ingredient(s): Polyoxyl 35 Castor Oil

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur. Macrogolglycerol Ricinoleate 35; USP-NF, JPE: Polyoxyl 35 Castor Oil

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic emulsifier for O-W emulsions, Solubilizer

Ingredient(s): Polyoxyl 35 Castor Oil

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur. Macrogolglycerol Ricinoleate 35; USP-NF, JPE: Polyoxyl 35 Castor Oil

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Nonionic emulsifier for O-W emulsions, Solubilizer

Ingredient(s): Polyoxyl 35 Castor Oil

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur. Macrogolglycerol Ricinoleate 35; USP-NF, JPE: Polyoxyl 35 Castor Oil

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dissolution enhancer, lubricant & wetting agent, drug solubilizer, plasticizer, thermoreversible gelling effect.

Ingredient(s): Poloxamer

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 188; JPE: Polyoxyethylene (160) Polyoxypropylene (30) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dissolution enhancer, lubricant & wetting agent, drug solubilizer, plasticizer, thermoreversible gelling effect.

Ingredient(s): Poloxamer

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 188; JPE: Polyoxyethylene (160) Polyoxypropylene (30) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dissolution enhancer, lubricant & wetting agent, drug solubilizer, plasticizer, thermoreversible gelling effect.

Ingredient(s): Poloxamer

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 188; JPE: Polyoxyethylene (160) Polyoxypropylene (30) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dissolution enhancer, lubricant & wetting agent, drug solubilizer, plasticizer, thermoreversible gelling effect.

Ingredient(s): Poloxamer

Dosage Form:

Category: Lubricants & Glidants

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 188; JPE: Polyoxyethylene (160) Polyoxypropylene (30) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dissolution enhancer, lubricant & wetting agent, drug solubilizer, plasticizer, thermoreversible gelling effect.

Ingredient(s): Poloxamer

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 188; JPE: Polyoxyethylene (160) Polyoxypropylene (30) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dissolution enhancer, lubricant & wetting agent, drug solubilizer, plasticizer, thermoreversible gelling effect.

Ingredient(s): Poloxamer

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 188; JPE: Polyoxyethylene (160) Polyoxypropylene (30) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dissolution enhancer, lubricant & wetting agent, drug solubilizer, plasticizer, thermoreversible gelling effect.

Ingredient(s): Poloxamer

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 188; JPE: Polyoxyethylene (160) Polyoxypropylene (30) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dissolution enhancer, lubricant & wetting agent, drug solubilizer, plasticizer, thermoreversible gelling effect.

Ingredient(s): Poloxamer

Dosage Form:

Category: Lubricants & Glidants

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 188; JPE: Polyoxyethylene (160) Polyoxypropylene (30) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dissolution enhancer, lubricant & wetting agent, drug solubilizer, plasticizer, thermoreversible gelling effect.

Ingredient(s): Poloxamer

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 188; JPE: Polyoxyethylene (160) Polyoxypropylene (30) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dissolution enhancer, lubricant & wetting agent, drug solubilizer, plasticizer, thermoreversible gelling effect.

Ingredient(s): Poloxamer

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 188; JPE: Polyoxyethylene (160) Polyoxypropylene (30) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dissolution enhancer, lubricant & wetting agent, drug solubilizer, plasticizer, thermoreversible gelling effect.

Ingredient(s): Poloxamer

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 188; JPE: Polyoxyethylene (160) Polyoxypropylene (30) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dissolution enhancer, lubricant & wetting agent, drug solubilizer, plasticizer, thermoreversible gelling effect.

Ingredient(s): Poloxamer

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 188; JPE: Polyoxyethylene (160) Polyoxypropylene (30) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dissolution enhancer, lubricant & wetting agent, drug solubilizer, plasticizer, thermoreversible gelling effect.

Ingredient(s): Poloxamer

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 188; JPE: Polyoxyethylene (160) Polyoxypropylene (30) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dissolution enhancer, lubricant & wetting agent, drug solubilizer, plasticizer, thermoreversible gelling effect.

Ingredient(s): Poloxamer

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 188; JPE: Polyoxyethylene (160) Polyoxypropylene (30) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dissolution enhancer, lubricant & wetting agent, drug solubilizer, plasticizer, thermoreversible gelling effect.

Ingredient(s): Poloxamer

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 188; JPE: Polyoxyethylene (160) Polyoxypropylene (30) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dissolution enhancer, lubricant & wetting agent, drug solubilizer, plasticizer, thermoreversible gelling effect.

Ingredient(s): Poloxamer

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 188; JPE: Polyoxyethylene (160) Polyoxypropylene (30) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dissolution enhancer, lubricant & wetting agent, drug solubilizer, plasticizer, thermoreversible gelling effect.

Ingredient(s): Poloxamer

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 188; JPE: Polyoxyethylene (160) Polyoxypropylene (30) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dissolution enhancer, lubricant & wetting agent, drug solubilizer, plasticizer, thermoreversible gelling effect.

Ingredient(s): Poloxamer

Dosage Form:

Category: Lubricants & Glidants

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 188; JPE: Polyoxyethylene (160) Polyoxypropylene (30) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dissolution enhancer, lubricant & wetting agent, drug solubilizer, plasticizer, thermoreversible gelling effect.

Ingredient(s): Poloxamer

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 188; JPE: Polyoxyethylene (160) Polyoxypropylene (30) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dissolution enhancer, lubricant & wetting agent, drug solubilizer, plasticizer, thermoreversible gelling effect.

Ingredient(s): Poloxamer

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 188; JPE: Polyoxyethylene (160) Polyoxypropylene (30) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dissolution enhancer, lubricant & wetting agent, drug solubilizer, plasticizer, thermoreversible gelling effect.

Ingredient(s): Poloxamer

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 188; JPE: Polyoxyethylene (160) Polyoxypropylene (30) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dissolution enhancer, lubricant & wetting agent, drug solubilizer, plasticizer, thermoreversible gelling effect.

Ingredient(s): Poloxamer

Dosage Form:

Category: Lubricants & Glidants

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 188; JPE: Polyoxyethylene (160) Polyoxypropylene (30) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilization, dispersion, crystallization inhibition, instant release matrices & spray drying

Ingredient(s): Povidone

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Povidone

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilization, dispersion, crystallization inhibition, instant release matrices & spray drying

Ingredient(s): Povidone

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Povidone

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilization, dispersion, crystallization inhibition, instant release matrices & spray drying

Ingredient(s): Povidone

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Povidone

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilization, dispersion, crystallization inhibition, instant release matrices & spray drying

Ingredient(s): Povidone

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Povidone

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilization, dispersion, crystallization inhibition, instant release matrices & spray drying

Ingredient(s): Povidone

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Povidone

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilization, dispersion, crystallization inhibition, instant release matrices & spray drying

Ingredient(s): Povidone

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Povidone

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

KOLLICOAT IR

URL Supplier Web Content
LM Application #LearnMore

Applications:

For Instant Release Coating, Powerful and peroxide free wet binder for oxidation-sensitive drugs. Flexible and wash resistant film former in topical films.

Ingredient(s): Polyvinyl Alcohol Graft Polyethylene Glycol Copolymer

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Macrogol Poly(vinyl alcohol) Grafted Copolymer; USP-NF: Ethylene Glycol and Vinyl Alcohol Graft Copolymer; JPE: Methacrylic Acid Copolymer LD

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

KOLLICOAT IR

URL Supplier Web Content
LM Application #LearnMore

Applications:

For Instant Release Coating, Powerful and peroxide free wet binder for oxidation-sensitive drugs. Flexible and wash resistant film former in topical films.

Ingredient(s): Polyvinyl Alcohol Graft Polyethylene Glycol Copolymer

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Macrogol Poly(vinyl alcohol) Grafted Copolymer; USP-NF: Ethylene Glycol and Vinyl Alcohol Graft Copolymer; JPE: Methacrylic Acid Copolymer LD

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

KOLLICOAT IR

URL Supplier Web Content
LM Application #LearnMore

Applications:

For Instant Release Coating, Powerful and peroxide free wet binder for oxidation-sensitive drugs. Flexible and wash resistant film former in topical films.

Ingredient(s): Polyvinyl Alcohol Graft Polyethylene Glycol Copolymer

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Macrogol Poly(vinyl alcohol) Grafted Copolymer; USP-NF: Ethylene Glycol and Vinyl Alcohol Graft Copolymer; JPE: Methacrylic Acid Copolymer LD

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

KOLLICOAT IR

URL Supplier Web Content
LM Application #LearnMore

Applications:

For Instant Release Coating, Powerful and peroxide free wet binder for oxidation-sensitive drugs. Flexible and wash resistant film former in topical films.

Ingredient(s): Polyvinyl Alcohol Graft Polyethylene Glycol Copolymer

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Macrogol Poly(vinyl alcohol) Grafted Copolymer; USP-NF: Ethylene Glycol and Vinyl Alcohol Graft Copolymer; JPE: Methacrylic Acid Copolymer LD

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

KOLLICOAT IR

URL Supplier Web Content
LM Application #LearnMore

Applications:

For Instant Release Coating, Powerful and peroxide free wet binder for oxidation-sensitive drugs. Flexible and wash resistant film former in topical films.

Ingredient(s): Polyvinyl Alcohol Graft Polyethylene Glycol Copolymer

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Macrogol Poly(vinyl alcohol) Grafted Copolymer; USP-NF: Ethylene Glycol and Vinyl Alcohol Graft Copolymer; JPE: Methacrylic Acid Copolymer LD

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

KOLLICOAT IR

URL Supplier Web Content
LM Application #LearnMore

Applications:

For Instant Release Coating, Powerful and peroxide free wet binder for oxidation-sensitive drugs. Flexible and wash resistant film former in topical films.

Ingredient(s): Polyvinyl Alcohol Graft Polyethylene Glycol Copolymer

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Macrogol Poly(vinyl alcohol) Grafted Copolymer; USP-NF: Ethylene Glycol and Vinyl Alcohol Graft Copolymer; JPE: Methacrylic Acid Copolymer LD

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

KOLLICOAT IR

URL Supplier Web Content
LM Application #LearnMore

Applications:

For Instant Release Coating, Powerful and peroxide free wet binder for oxidation-sensitive drugs. Flexible and wash resistant film former in topical films.

Ingredient(s): Polyvinyl Alcohol Graft Polyethylene Glycol Copolymer

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Macrogol Poly(vinyl alcohol) Grafted Copolymer; USP-NF: Ethylene Glycol and Vinyl Alcohol Graft Copolymer; JPE: Methacrylic Acid Copolymer LD

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

KOLLICOAT IR

URL Supplier Web Content
LM Application #LearnMore

Applications:

For Instant Release Coating, Powerful and peroxide free wet binder for oxidation-sensitive drugs. Flexible and wash resistant film former in topical films.

Ingredient(s): Polyvinyl Alcohol Graft Polyethylene Glycol Copolymer

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Macrogol Poly(vinyl alcohol) Grafted Copolymer; USP-NF: Ethylene Glycol and Vinyl Alcohol Graft Copolymer; JPE: Methacrylic Acid Copolymer LD

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

KOLLICOAT IR

URL Supplier Web Content
LM Application #LearnMore

Applications:

For Instant Release Coating, Powerful and peroxide free wet binder for oxidation-sensitive drugs. Flexible and wash resistant film former in topical films.

Ingredient(s): Polyvinyl Alcohol Graft Polyethylene Glycol Copolymer

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Macrogol Poly(vinyl alcohol) Grafted Copolymer; USP-NF: Ethylene Glycol and Vinyl Alcohol Graft Copolymer; JPE: Methacrylic Acid Copolymer LD

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

KOLLICOAT IR

URL Supplier Web Content
LM Application #LearnMore

Applications:

For Instant Release Coating, Powerful and peroxide free wet binder for oxidation-sensitive drugs. Flexible and wash resistant film former in topical films.

Ingredient(s): Polyvinyl Alcohol Graft Polyethylene Glycol Copolymer

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Macrogol Poly(vinyl alcohol) Grafted Copolymer; USP-NF: Ethylene Glycol and Vinyl Alcohol Graft Copolymer; JPE: Methacrylic Acid Copolymer LD

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

KOLLICREAM 3C

URL Supplier Web Content
LM Application #LearnMore

Applications:

Medium spreadability, extremely mild, solvent for lipophilic drugs, enhances skin penetration

Ingredient(s): Cocoyl Caprylocaprate

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Cocoyl caprylocaprate, Coco-caprylate-caprate

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

KOLLICREAM 3C

URL Supplier Web Content
LM Application #LearnMore

Applications:

Medium spreadability, extremely mild, solvent for lipophilic drugs, enhances skin penetration

Ingredient(s): Cocoyl Caprylocaprate

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Cocoyl caprylocaprate, Coco-caprylate-caprate

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

KOLLICREAM 3C

URL Supplier Web Content
LM Application #LearnMore

Applications:

Medium spreadability, extremely mild, solvent for lipophilic drugs, enhances skin penetration

Ingredient(s): Cocoyl Caprylocaprate

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Cocoyl caprylocaprate, Coco-caprylate-caprate

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solid, slow spreading with rich feeling. Solvent for lipophilic drugs.

Ingredient(s): Cetyl Palmitate

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur: Cetyl palmitate 15

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solid, slow spreading with rich feeling. Solvent for lipophilic drugs.

Ingredient(s): Cetyl Palmitate

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur: Cetyl palmitate 15

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Medium spreadability, Solvent for lipophilic drugs, enhances skin penetration.

Ingredient(s): Decyl Oleate

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Decyl oleate

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Medium spreadability, Solvent for lipophilic drugs, enhances skin penetration.

Ingredient(s): Decyl Oleate

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Decyl oleate

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Medium spreadability, Solvent for lipophilic drugs, enhances skin penetration.

Ingredient(s): Decyl Oleate

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Decyl oleate

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Fast spreading with light & fresh feeling, solvent for lipophilic drugs, enhances skin penetration

Ingredient(s): Isopropyl Myristate

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Isopropyl myristate

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Fast spreading with light & fresh feeling, solvent for lipophilic drugs, enhances skin penetration

Ingredient(s): Isopropyl Myristate

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Isopropyl myristate

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Fast spreading with light & fresh feeling, solvent for lipophilic drugs, enhances skin penetration

Ingredient(s): Isopropyl Myristate

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Isopropyl myristate

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Medium spreadability, solvent for lipophilic drugs, enhances skin penetration

Ingredient(s): Oleyl Alcohol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Oleyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Medium spreadability, solvent for lipophilic drugs, enhances skin penetration

Ingredient(s): Oleyl Alcohol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Oleyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Medium spreadability, solvent for lipophilic drugs, enhances skin penetration

Ingredient(s): Oleyl Alcohol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Oleyl alcohol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Medium spreadability, solvent for lipophilic drugs, enhances skin penetration, effective in exceptionally wide pH range

Ingredient(s): Octyldodecanol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Octyldodecanol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Medium spreadability, solvent for lipophilic drugs, enhances skin penetration, effective in exceptionally wide pH range

Ingredient(s): Octyldodecanol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Octyldodecanol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Medium spreadability, solvent for lipophilic drugs, enhances skin penetration, effective in exceptionally wide pH range

Ingredient(s): Octyldodecanol

Dosage Form:

Category: Topical

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Octyldodecanol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Flexible water soluble instant release coating polymer, especially used for moisture protection

Ingredient(s): Polyvinyl Alcohol Graft Polyethylene Glycol Copolymer, Polyvinyl Alcohol

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Excipient based on Kollicoat® IR and monographed raw materials

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Flexible water soluble instant release coating polymer, especially used for moisture protection

Ingredient(s): Polyvinyl Alcohol Graft Polyethylene Glycol Copolymer, Polyvinyl Alcohol

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Excipient based on Kollicoat® IR and monographed raw materials

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Flexible water soluble instant release coating polymer, especially used for moisture protection

Ingredient(s): Polyvinyl Alcohol Graft Polyethylene Glycol Copolymer, Polyvinyl Alcohol

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Excipient based on Kollicoat® IR and monographed raw materials

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Flexible water soluble instant release coating polymer, especially used for moisture protection

Ingredient(s): Polyvinyl Alcohol Graft Polyethylene Glycol Copolymer, Polyvinyl Alcohol

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Excipient based on Kollicoat® IR and monographed raw materials

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Flexible water soluble instant release coating polymer, especially used for moisture protection

Ingredient(s): Polyvinyl Alcohol Graft Polyethylene Glycol Copolymer, Polyvinyl Alcohol

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Excipient based on Kollicoat® IR and monographed raw materials

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Flexible water soluble instant release coating polymer, especially used for moisture protection

Ingredient(s): Polyvinyl Alcohol Graft Polyethylene Glycol Copolymer, Polyvinyl Alcohol

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Excipient based on Kollicoat® IR and monographed raw materials

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Flexible water soluble instant release coating polymer, especially used for moisture protection

Ingredient(s): Polyvinyl Alcohol Graft Polyethylene Glycol Copolymer, Polyvinyl Alcohol

Dosage Form:

Category: Coating Systems & Additives

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Excipient based on Kollicoat® IR and monographed raw materials

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Flexible water soluble instant release coating polymer, especially used for moisture protection

Ingredient(s): Polyvinyl Alcohol Graft Polyethylene Glycol Copolymer, Polyvinyl Alcohol

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Excipient based on Kollicoat® IR and monographed raw materials

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dissolution enhancer, lubricant & wetting agent, Hydrophilic lubricant, effervescent tablets.

Ingredient(s): Poloxamer 188

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 188; JPE: Polyoxyethylene (160) Polyoxypropylene (30) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dissolution enhancer, lubricant & wetting agent, Hydrophilic lubricant, effervescent tablets.

Ingredient(s): Poloxamer 188

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 188; JPE: Polyoxyethylene (160) Polyoxypropylene (30) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dissolution enhancer, lubricant & wetting agent, Hydrophilic lubricant, effervescent tablets.

Ingredient(s): Poloxamer 407

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 407; JPE: Polyoxyethylene (196) Polyoxypropylene (67) glyco

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Dissolution enhancer, lubricant & wetting agent, Hydrophilic lubricant, effervescent tablets.

Ingredient(s): Poloxamer 407

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 407; JPE: Polyoxyethylene (196) Polyoxypropylene (67) glyco

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Liquid plasticizer, Solvent for oral and topical applications, Hydrophilic fill for solubilization of hydrophilic APIs.

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., JP, FCC, USP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Liquid plasticizer, Solvent for oral and topical applications, Hydrophilic fill for solubilization of hydrophilic APIs.

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., JP, FCC, USP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Liquid plasticizer, Solvent for oral and topical applications, Hydrophilic fill for solubilization of hydrophilic APIs.

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., JP, FCC, USP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Liquid plasticizer, Solvent for oral and topical applications, Hydrophilic fill for solubilization of hydrophilic APIs.

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., JP, FCC, USP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Liquid plasticizer, Solvent for oral and topical applications, Hydrophilic fill for solubilization of hydrophilic APIs.

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., JP, FCC, USP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Liquid plasticizer, Solvent for oral and topical applications, Hydrophilic fill for solubilization of hydrophilic APIs.

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., JP, FCC, USP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Polymeric solubilizer, emulsifier & plasticizer, enhances viscosity, thermoreversible gelling effect.

Ingredient(s): Poloxamer 407

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 407; JPE: Polyoxyethylene (196) Polyoxypropylene (67) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Polymeric solubilizer, emulsifier & plasticizer, enhances viscosity, thermoreversible gelling effect.

Ingredient(s): Poloxamer 407

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 407; JPE: Polyoxyethylene (196) Polyoxypropylene (67) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Polymeric solubilizer, emulsifier & plasticizer, enhances viscosity, thermoreversible gelling effect.

Ingredient(s): Poloxamer 407

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 407; JPE: Polyoxyethylene (196) Polyoxypropylene (67) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Polymeric solubilizer, emulsifier & plasticizer, enhances viscosity, thermoreversible gelling effect.

Ingredient(s): Poloxamer 407

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 407; JPE: Polyoxyethylene (196) Polyoxypropylene (67) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Polymeric solubilizer, emulsifier & plasticizer, enhances viscosity, thermoreversible gelling effect.

Ingredient(s): Poloxamer 407

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 407; JPE: Polyoxyethylene (196) Polyoxypropylene (67) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Polymeric solubilizer, emulsifier & plasticizer, enhances viscosity, thermoreversible gelling effect.

Ingredient(s): Poloxamer 407

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 407; JPE: Polyoxyethylene (196) Polyoxypropylene (67) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Polymeric solubilizer, emulsifier & plasticizer, enhances viscosity, thermoreversible gelling effect.

Ingredient(s): Poloxamer 407

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 407; JPE: Polyoxyethylene (196) Polyoxypropylene (67) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Polymeric solubilizer, emulsifier & plasticizer, enhances viscosity, thermoreversible gelling effect.

Ingredient(s): Poloxamer 407

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 407; JPE: Polyoxyethylene (196) Polyoxypropylene (67) glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Polymeric solubilizer, emulsifier & plasticizer, enhances viscosity, thermoreversible gelling effect.

Ingredient(s): Poloxamer 338

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Polymeric solubilizer, emulsifier & plasticizer, enhances viscosity, thermoreversible gelling effect.

Ingredient(s): Poloxamer 338

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Polymeric solubilizer, emulsifier & plasticizer, enhances viscosity, thermoreversible gelling effect.

Ingredient(s): Poloxamer 338

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Polymeric solubilizer, emulsifier & plasticizer, enhances viscosity, thermoreversible gelling effect.

Ingredient(s): Poloxamer 338

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Polymeric solubilizer, emulsifier & plasticizer, enhances viscosity, thermoreversible gelling effect.

Ingredient(s): Poloxamer 338

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Polymeric solubilizer, emulsifier & plasticizer, enhances viscosity, thermoreversible gelling effect.

Ingredient(s): Poloxamer 338

Dosage Form:

Category: Thickeners and Stabilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Tablet binding, thickener, stabilizers of suspensions, reduces sedimentation, crystallization inhibition.

Ingredient(s): Povidone

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Povidone

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Tablet binding, thickener, stabilizers of suspensions, reduces sedimentation, crystallization inhibition.

Ingredient(s): Povidone

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Povidone

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Tablet binding, thickener, stabilizers of suspensions, reduces sedimentation, crystallization inhibition.

Ingredient(s): Povidone

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Povidone

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Tablet binding, thickener, stabilizers of suspensions, reduces sedimentation, crystallization inhibition.

Ingredient(s): Povidone

Dosage Form:

Category: Fillers, Diluents & Binders

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Povidone

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Tablet binding, thickener, stabilizers of suspensions, reduces sedimentation, crystallization inhibition.

Ingredient(s): Povidone

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Povidone

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Tablet binding, thickener, stabilizers of suspensions, reduces sedimentation, crystallization inhibition.

Ingredient(s): Povidone

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Povidone

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Tablet binding, thickener, stabilizers of suspensions, reduces sedimentation, crystallization inhibition.

Ingredient(s): Povidone

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Povidone

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Tablet binding, thickener, stabilizers of suspensions, reduces sedimentation, crystallization inhibition.

Ingredient(s): Povidone

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Povidone

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubility and bioavailability enhancement, ideal for hot melt extrusion (HME)

Ingredient(s): polyethylene glycol, Polyvinyl Acetate

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Polyvinyl caprolactam – polyvinyl acetate – polyethylene glycol graft copolymer

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubility and bioavailability enhancement, ideal for hot melt extrusion (HME)

Ingredient(s): polyethylene glycol, Polyvinyl Acetate

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Polyvinyl caprolactam – polyvinyl acetate – polyethylene glycol graft copolymer

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubility and bioavailability enhancement, ideal for hot melt extrusion (HME)

Ingredient(s): polyethylene glycol, Polyvinyl Acetate

Dosage Form:

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Polyvinyl caprolactam – polyvinyl acetate – polyethylene glycol graft copolymer

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubility and bioavailability enhancement, ideal for hot melt extrusion (HME)

Ingredient(s): polyethylene glycol, Polyvinyl Acetate

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Polyvinyl caprolactam – polyvinyl acetate – polyethylene glycol graft copolymer

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubility and bioavailability enhancement, ideal for hot melt extrusion (HME)

Ingredient(s): polyethylene glycol, Polyvinyl Acetate

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Polyvinyl caprolactam – polyvinyl acetate – polyethylene glycol graft copolymer

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Liquid plasticizer, solvent for oral and topical applications, hydrophilic fill for solubilization of hydrophilic APIs.

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., JP, FCC, USP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Liquid plasticizer, solvent for oral and topical applications, hydrophilic fill for solubilization of hydrophilic APIs.

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., JP, FCC, USP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Liquid plasticizer, solvent for oral and topical applications, hydrophilic fill for solubilization of hydrophilic APIs.

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., JP, FCC, USP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Liquid plasticizer for tablet coatings, solvent for APIs, dispersing agent, stabilizer and co-emulsifier in semi-solid formulations.

Ingredient(s): Poloxamer 124

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 124; JPE: Polyoxyethylene (20) Polyoxypropylene (20) Glycol

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Ludiflash is a ready-to-use orally disintegrating tablet (ODT) solution with superior mouthfeel.

Ingredient(s): Crospovidone, Mannitol, Polyvinyl Acetate

Dosage Form:

Category: Chewable & Orodispersible Aids

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: 90 % mannitol, 5 % crospovidone, 5 % polyvinyl acetate

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Ludiflash is a ready-to-use orally disintegrating tablet (ODT) solution with superior mouthfeel.

Ingredient(s): Crospovidone, Mannitol, Polyvinyl Acetate

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: 90 % mannitol, 5 % crospovidone, 5 % polyvinyl acetate

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Ludiflash is a ready-to-use orally disintegrating tablet (ODT) solution with superior mouthfeel.

Ingredient(s): Crospovidone, Mannitol, Polyvinyl Acetate

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: 90 % mannitol, 5 % crospovidone, 5 % polyvinyl acetate

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Kollidon CL-F has a balance of strong disintegration and optimal surface homogeneity.

Ingredient(s): Crospovidone

Dosage Form:

Category: Disintegrants & Superdisintegrants

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type A

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Kollidon CL-F has a balance of strong disintegration and optimal surface homogeneity.

Ingredient(s): Crospovidone

Dosage Form:

Category: Disintegrants & Superdisintegrants

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type A

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Kollidon CL-F has a balance of strong disintegration and optimal surface homogeneity.

Ingredient(s): Crospovidone

Dosage Form:

Category: Disintegrants & Superdisintegrants

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type A

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Kollidon CL-F has a balance of strong disintegration and optimal surface homogeneity.

Ingredient(s): Crospovidone

Dosage Form:

Category: Disintegrants & Superdisintegrants

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type A

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Kollidon CL-F has a balance of strong disintegration and optimal surface homogeneity.

Ingredient(s): Crospovidone

Dosage Form:

Category: Chewable & Orodispersible Aids

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type A

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Kollidon CL-F has a balance of strong disintegration and optimal surface homogeneity.

Ingredient(s): Crospovidone

Dosage Form:

Category: Chewable & Orodispersible Aids

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type A

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Kollidon CL-F has a balance of strong disintegration and optimal surface homogeneity.

Ingredient(s): Crospovidone

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type A

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Kollidon CL-F has a balance of strong disintegration and optimal surface homogeneity.

Ingredient(s): Crospovidone

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type A

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Kollidon CL-F has a balance of strong disintegration and optimal surface homogeneity.

Ingredient(s): Crospovidone

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type A

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Kollidon CL-SF acts as a dry binder and super disintegrant suitable for small tablets and orally disintegrating tablets (ODTs). It provides pleasant mouthfeel due to finer particles.

Ingredient(s): Crospovidone

Dosage Form:

Category: Chewable & Orodispersible Aids

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type B

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Kollidon CL-SF acts as a dry binder and super disintegrant suitable for small tablets and orally disintegrating tablets (ODTs). It provides pleasant mouthfeel due to finer particles.

Ingredient(s): Crospovidone

Dosage Form:

Category: Chewable & Orodispersible Aids

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type B

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Kollidon CL-SF acts as a dry binder and super disintegrant suitable for small tablets and orally disintegrating tablets (ODTs). It provides pleasant mouthfeel due to finer particles.

Ingredient(s): Crospovidone

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type B

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Kollidon CL-SF acts as a dry binder and super disintegrant suitable for small tablets and orally disintegrating tablets (ODTs). It provides pleasant mouthfeel due to finer particles.

Ingredient(s): Crospovidone

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type B

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Kollidon CL-SF acts as a dry binder and super disintegrant suitable for small tablets and orally disintegrating tablets (ODTs). It provides pleasant mouthfeel due to finer particles.

Ingredient(s): Crospovidone

Dosage Form:

Category: Direct Compression

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type B

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Kollidon CL-SF acts as a dry binder and super disintegrant suitable for small tablets and orally disintegrating tablets (ODTs). It provides pleasant mouthfeel due to finer particles.

Ingredient(s): Crospovidone

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type B

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Kollidon CL-SF acts as a dry binder and super disintegrant suitable for small tablets and orally disintegrating tablets (ODTs). It provides pleasant mouthfeel due to finer particles.

Ingredient(s): Crospovidone

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type B

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Kollidon CL-SF acts as a dry binder and super disintegrant suitable for small tablets and orally disintegrating tablets (ODTs). It provides pleasant mouthfeel due to finer particles.

Ingredient(s): Crospovidone

Dosage Form:

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type B

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilizing matrix, crystallization inhibitor & stabilizer in injectables and ophthalmic products

Ingredient(s): Povidone

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP: Povidone; JPE: Povidone K 17

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilizing matrix, crystallization inhibitor & stabilizer in injectables and ophthalmic products

Ingredient(s): Povidone

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP: Povidone; JPE: Povidone K 17

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilizing matrix, crystallization inhibitor & stabilizer in injectables and ophthalmic products

Ingredient(s): Povidone

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP: Povidone; JPE: Povidone K 17

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilizing matrix, crystallization inhibitor & stabilizer in injectables and ophthalmic products

Ingredient(s): Povidone

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP: Povidone; JPE: Povidone K 17

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilizing matrix, crystallization inhibitor & stabilizer in injectables and ophthalmic products

Ingredient(s): Povidone

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP: Povidone; JPE: Povidone K 17

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilizing matrix, crystallization inhibitor & stabilizer in injectables and ophthalmic products

Ingredient(s): Povidone

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP: Povidone; JPE: Povidone K 17

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilizing matrix, crystallization inhibitor & stabilizer in injectables and ophthalmic products

Ingredient(s): Povidone

Dosage Form:

Category: Parenteral

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP: Povidone; JPE: Povidone K 17

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilizing matrix, crystallization inhibitor & stabilizer in injectables and ophthalmic products

Ingredient(s): Povidone

Dosage Form:

Category: Parenteral

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP: Povidone; JPE: Povidone K 17

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilizing matrix, crystallization inhibitor & stabilizer in injectables and ophthalmic products

Ingredient(s): Povidone

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilizing matrix, crystallization inhibitor & stabilizer in injectables and ophthalmic products

Ingredient(s): Povidone

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilizing matrix, crystallization inhibitor & stabilizer in injectables and ophthalmic products

Ingredient(s): Povidone

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilizing matrix, crystallization inhibitor & stabilizer in injectables and ophthalmic products

Ingredient(s): Povidone

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilizing matrix, crystallization inhibitor & stabilizer in injectables and ophthalmic products

Ingredient(s): Povidone

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilizing matrix, crystallization inhibitor & stabilizer in injectables and ophthalmic products

Ingredient(s): Povidone

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilizing matrix, crystallization inhibitor & stabilizer in injectables and ophthalmic products

Ingredient(s): Povidone

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilizing matrix, crystallization inhibitor & stabilizer in injectables and ophthalmic products

Ingredient(s): Povidone

Dosage Form:

Category: Parenteral

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilizing matrix, crystallization inhibitor & stabilizer in injectables and ophthalmic products

Ingredient(s): Povidone

Dosage Form:

Category: Parenteral

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

For sensitive active ingredients to improve their stability

Ingredient(s): Polyoxyl 35 Castor Oil

Dosage Form:

Category: API Stability Enhancers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Macrogolglycerol Ricinoleate 35; USP-NF: Polyoxyl 35 Castor Oil

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

For sensitive active ingredients to improve their stability

Ingredient(s): Polyoxyl 35 Castor Oil

Dosage Form:

Category: API Stability Enhancers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Macrogolglycerol Ricinoleate 35; USP-NF: Polyoxyl 35 Castor Oil

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

For sensitive active ingredients to improve their stability

Ingredient(s): Polyoxyl 35 Castor Oil

Dosage Form:

Category: API Stability Enhancers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Macrogolglycerol Ricinoleate 35; USP-NF: Polyoxyl 35 Castor Oil

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Hydrophilic fill for solubilization of hydrophilic APIs.

Ingredient(s): polyethylene glycol

Dosage Form:

Category: Solubilizers

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., JP, FCC, USP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
First
Last
Post Enquiry
POST ENQUIRY